Biblio Discovery — Demo Discovery Service

6 hasil untuk "Ming FENG"

Menampilkan 1–6 · 2,73 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease

    Jung‐Lung Hsu; Yi‐Chia Wei; Cheng‐Hong Toh dkk.

    Annals of Neurology · 2022 · Inggris · OpenAlex Scopus

    OBJECTIVE: The glymphatic system cleans amyloid and tau proteins from the brain in animal studies of Alzheimer disease (AD). However, there is no direct evidence showing this in humans. METHODS: Participants (n = 50, 62.6 ± 5.4 years old, 36 women) with AD and normal controls underwent amyloid…

  2. Artikel Jurnal Teks lengkap

    Drivers and impacts of the most extreme marine heatwave events

    Alex Sen Gupta; Mads Solgaard Thomsen; Jessica A. Benthuysen dkk.

    Scientific Reports · 2020 · Inggris · OpenAlex Scopus

    Prolonged high-temperature extreme events in the ocean, marine heatwaves, can have severe and long-lasting impacts on marine ecosystems, fisheries and associated services. This study applies a marine heatwave framework to analyse a global sea surface temperature product and identify the most…

  3. Artikel Jurnal

    Observation of the fastest chemical processes in the radiolysis of water

    Zhi-Heng Loh; Gilles Doumy; C. Arnold dkk.

    Science · 2020 · Inggris · OpenAlex Scopus

    The “hole” story of water ionization The direct observation of the cationic hole H 2 O + that is formed in liquid water after ionization has been a long-standing experimental challenge. Previous attempts using optical and ultraviolet techniques have failed to reveal its key spectroscopic signature…

  4. Artikel Jurnal Teks lengkap

    Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

    Cristina Saura; Mafalda Oliveira; Yin‐Hsun Feng dkk.

    Journal of Clinical Oncology · 2020 · Inggris · OpenAlex Scopus

    PURPOSE NALA (ClinicalTrials.gov identifier: NCT01808573 ) is a randomized, active-controlled, phase III trial comparing neratinib, an irreversible pan-HER tyrosine kinase inhibitor (TKI), plus capecitabine (N+C) against lapatinib, a reversible dual TKI, plus capecitabine (L+C) in patients with…